In the last 12 months, insiders at LeonaBio, Inc. ($LONA) filed 203 transactions with the SEC: 18 open-market purchases totaling $1,878,313 and 35 sales totaling $232,254. Net insider sentiment: net buying.
LeonaBio, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- PERCEPTIVE ADVISORS LLC (Director) — 12 transactions totaling $9,838,748
- Gengos Andrew (See Below) — 13 transactions totaling $246,533
- Romano Kelly A (Not found) — 4 transactions totaling $100,051
- PICKERING GRANT (Director) — 3 transactions totaling $60,350
- CHURCH KEVIN (CHIEF SCIENTIFIC OFFICER) — 28 transactions totaling $52,274
View all SEC Filings for LeonaBio, Inc. (LONA).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 5856 | $0.00 | 26,537.0000 | 3,943,887 | 28.32% | 0.15% |
| March 4, 2026 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 1359 | $5.37 | 25,178.0000 | 3,943,887 | 5.12% | 0.03% |
| March 3, 2026 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | M | Restricted Stock Units | 5856 | $0.00 | 0.0000 | 3,943,887 | 100.00% | 0.15% |
| March 3, 2026 | San Martin Javier | CHIEF MEDICAL OFFICER | M | Common Stock | 7418 | $0.00 | 17,607.0000 | 3,943,887 | 72.80% | 0.19% |
| March 4, 2026 | San Martin Javier | CHIEF MEDICAL OFFICER | S | Common Stock | 1720 | $5.37 | 15,887.0000 | 3,943,887 | 9.77% | 0.04% |
| March 3, 2026 | San Martin Javier | CHIEF MEDICAL OFFICER | M | Restricted Stock Units | 7418 | $0.00 | 0.0000 | 3,943,887 | 100.00% | 0.19% |
| March 3, 2026 | Litton Mark James | PRESIDENT and CEO | M | Common Stock | 22254 | $0.00 | 65,050.0000 | 3,943,887 | 52.00% | 0.56% |
| March 4, 2026 | Litton Mark James | PRESIDENT and CEO | S | Common Stock | 5156 | $5.37 | 59,894.0000 | 3,943,887 | 7.93% | 0.13% |
| March 3, 2026 | Litton Mark James | PRESIDENT and CEO | M | Restricted Stock Units | 22254 | $0.00 | 0.0000 | 3,943,887 | 100.00% | 0.56% |
| March 3, 2026 | Renninger Robert | CHIEF FINANCIAL OFFICER | M | Common Stock | 3900 | $0.00 | 16,757.0000 | 3,943,887 | 30.33% | 0.10% |
| March 4, 2026 | Renninger Robert | CHIEF FINANCIAL OFFICER | S | Common Stock | 906 | $5.37 | 15,851.0000 | 3,943,887 | 5.41% | 0.02% |
| March 3, 2026 | Renninger Robert | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 3900 | $0.00 | 0.0000 | 3,943,887 | 100.00% | 0.10% |
| March 3, 2026 | Worthington Mark | GENERAL COUNSEL and CCO | M | Common Stock | 5726 | $0.00 | 19,704.0000 | 3,943,887 | 40.96% | 0.15% |
| March 4, 2026 | Worthington Mark | GENERAL COUNSEL and CCO | S | Common Stock | 1328 | $5.37 | 18,376.0000 | 3,943,887 | 6.74% | 0.03% |
| March 3, 2026 | Worthington Mark | GENERAL COUNSEL and CCO | M | Restricted Stock Units | 5726 | $0.00 | 0.0000 | 3,943,887 | 100.00% | 0.15% |
| Dec. 31, 2025 | Renninger Robert | Chief Financial Officer | M | Restricted Stock Units | 1236 | $0.00 | 0.0000 | 3,943,887 | 100.00% | 0.03% |
| Dec. 31, 2025 | Worthington Mark | General Counsel and CCO | M | Restricted Stock Units | 3667 | $0.00 | 0.0000 | 3,943,887 | 100.00% | 0.09% |
| Jan. 2, 2026 | Worthington Mark | General Counsel and CCO | S | Common Stock | 876 | $6.88 | 13,978.0000 | 3,943,887 | 5.90% | 0.02% |
| Dec. 31, 2025 | Worthington Mark | General Counsel and CCO | M | Common Stock | 3667 | $0.00 | 14,854.0000 | 3,943,887 | 32.78% | 0.09% |
| Dec. 31, 2025 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | M | Restricted Stock Units | 3667 | $0.00 | 0.0000 | 3,943,887 | 100.00% | 0.09% |
| Jan. 2, 2026 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 876 | $6.88 | 20,681.0000 | 3,943,887 | 4.06% | 0.02% |
| Dec. 31, 2025 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 3667 | $0.00 | 21,557.0000 | 3,943,887 | 20.50% | 0.09% |
| Nov. 18, 2025 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | A | Common Stock | 1000 | $2.31 | 17,890.0000 | 3,943,887 | 5.92% | 0.03% |
| Dec. 31, 2025 | San Martin Javier | CHIEF MEDICAL OFFICER | M | Common Stock | 4667 | $0.00 | 11,833.0000 | 3,943,887 | 65.13% | 0.12% |
| Jan. 2, 2026 | San Martin Javier | CHIEF MEDICAL OFFICER | S | Common Stock | 1644 | $6.88 | 10,189.0000 | 3,943,887 | 13.89% | 0.04% |
| Dec. 31, 2025 | San Martin Javier | CHIEF MEDICAL OFFICER | M | Restricted Stock Units | 4667 | $0.00 | 0.0000 | 3,943,887 | 100.00% | 0.12% |
| Dec. 31, 2025 | Litton Mark James | President and CEO | M | Common Stock | 10834 | $0.00 | 45,382.0000 | 3,943,887 | 31.36% | 0.27% |
| Jan. 2, 2026 | Litton Mark James | President and CEO | S | Common Stock | 2586 | $6.88 | 42,796.0000 | 3,943,887 | 5.70% | 0.07% |
| Dec. 31, 2025 | Litton Mark James | President and CEO | M | Restricted Stock Units | 10834 | $0.00 | 0.0000 | 3,943,887 | 100.00% | 0.27% |
| Nov. 18, 2025 | Renninger Robert | Chief Financial Officer | A | Common Stock | 1000 | $2.31 | 11,918.0000 | 3,943,887 | 9.16% | 0.03% |
| Dec. 31, 2025 | Renninger Robert | Chief Financial Officer | M | Common Stock | 1236 | $0.00 | 13,154.0000 | 3,943,887 | 10.37% | 0.03% |
| Jan. 2, 2026 | Renninger Robert | Chief Financial Officer | S | Common Stock | 297 | $6.88 | 12,857.0000 | 3,943,887 | 2.26% | 0.01% |
| Dec. 24, 2025 | Worthington Mark | General Counsel and CCO | A | Stock Option (Right to Buy) | 34358 | $0.00 | 34,358.0000 | 3,943,887 | 9999.99% | 0.87% |
| Dec. 24, 2025 | Renninger Robert | Chief Financial Officer | A | Stock Option (Right to Buy) | 34358 | $0.00 | 34,358.0000 | 3,943,887 | 9999.99% | 0.87% |
| Dec. 24, 2025 | Litton Mark James | President and CEO | A | Stock Option (Right to Buy) | 133526 | $0.00 | 133,526.0000 | 3,943,887 | 9999.99% | 3.39% |
| Dec. 24, 2025 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 35138 | $0.00 | 35,138.0000 | 3,943,887 | 9999.99% | 0.89% |
| Dec. 24, 2025 | San Martin Javier | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 44508 | $0.00 | 44,508.0000 | 3,943,887 | 9999.99% | 1.13% |
| Dec. 23, 2025 | PERCEPTIVE ADVISORS LLC | Director | A | Series B Warrant (right to buy) | 3543307 | $6.35 | 3,543,307.0000 | 3,943,887 | 9999.99% | 89.84% |
| Dec. 23, 2025 | PERCEPTIVE ADVISORS LLC | Director | A | Pre-Funded Warrant (right to buy) | 457645 | $6.35 | 457,645.0000 | 3,943,887 | 9999.99% | 11.60% |
| Dec. 23, 2025 | PERCEPTIVE ADVISORS LLC | Director | A | Series A Warrant (right to buy) | 1279526 | $6.35 | 1,279,526.0000 | 3,943,887 | 9999.99% | 32.44% |
| Dec. 23, 2025 | PERCEPTIVE ADVISORS LLC | Director | A | Pre-Funded Warrant (right to buy) | 5502402 | $0.00 | 5,502,402.0000 | 3,943,887 | 9999.99% | 100.00% |
| Dec. 23, 2025 | PERCEPTIVE ADVISORS LLC | Director | A | Series B Warrant (right to buy) | 1181101 | $6.35 | 1,181,101.0000 | 3,943,887 | 9999.99% | 29.95% |
| Dec. 23, 2025 | PERCEPTIVE ADVISORS LLC | Director | A | Common Stock | 989270 | $6.35 | 1,529,566.0000 | 3,943,887 | 183.10% | 25.08% |
| Dec. 23, 2025 | PERCEPTIVE ADVISORS LLC | Director | A | Common Stock | 329756 | $6.35 | 329,756.0000 | 3,943,887 | 9999.99% | 8.36% |
| Dec. 23, 2025 | PERCEPTIVE ADVISORS LLC | Director | A | Pre-Funded Warrant (right to buy) | 1372935 | $6.35 | 1,372,935.0000 | 3,943,887 | 9999.99% | 34.81% |
| Dec. 23, 2025 | PERCEPTIVE ADVISORS LLC | Director | A | Series A Warrant (right to buy) | 3838583 | $6.35 | 3,838,583.0000 | 3,943,887 | 9999.99% | 97.33% |
| June 30, 2025 | Renninger Robert | SVP, Finance and Accounting | M | Restricted Stock Units | 12359 | $0.00 | 12,359.0000 | 39,042,445 | 50.00% | 0.03% |
| July 1, 2025 | San Martin Javier | CHIEF MEDICAL OFFICER | S | Common Stock | 10842 | $0.29 | 71,665.0000 | 39,042,445 | 13.14% | 0.03% |
| June 30, 2025 | San Martin Javier | CHIEF MEDICAL OFFICER | M | Restricted Stock Units | 46666 | $0.00 | 46,667.0000 | 39,042,445 | 50.00% | 0.12% |
| June 30, 2025 | Worthington Mark | General Counsel and CCO | M | Common Stock | 36666 | $0.00 | 120,401.0000 | 39,042,445 | 43.79% | 0.09% |
| July 1, 2025 | Worthington Mark | General Counsel and CCO | S | Common Stock | 8526 | $0.29 | 111,875.0000 | 39,042,445 | 7.08% | 0.02% |
| June 30, 2025 | Worthington Mark | General Counsel and CCO | M | Restricted Stock Units | 36666 | $0.00 | 36,667.0000 | 39,042,445 | 50.00% | 0.09% |
| May 19, 2025 | Renninger Robert | SVP, Finance and Accounting | A | Common Stock | 10000 | $0.23 | 99,724.0000 | 39,042,445 | 11.15% | 0.03% |
| June 30, 2025 | Renninger Robert | SVP, Finance and Accounting | M | Common Stock | 12359 | $0.00 | 112,083.0000 | 39,042,445 | 12.39% | 0.03% |
| July 1, 2025 | Renninger Robert | SVP, Finance and Accounting | S | Common Stock | 2897 | $0.29 | 109,186.0000 | 39,042,445 | 2.58% | 0.01% |
| June 30, 2025 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 36666 | $0.00 | 177,427.0000 | 39,042,445 | 26.05% | 0.09% |
| July 1, 2025 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 8526 | $0.29 | 168,901.0000 | 39,042,445 | 4.81% | 0.02% |
| June 30, 2025 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | M | Restricted Stock Units | 36666 | $0.00 | 36,667.0000 | 39,042,445 | 50.00% | 0.09% |
| June 30, 2025 | Litton Mark James | President and CEO | M | Common Stock | 108334 | $0.00 | 370,614.0000 | 39,042,445 | 41.30% | 0.28% |
| July 1, 2025 | Litton Mark James | President and CEO | S | Common Stock | 25123 | $0.29 | 345,491.0000 | 39,042,445 | 6.78% | 0.06% |
| June 30, 2025 | Litton Mark James | President and CEO | M | Restricted Stock Units | 108334 | $0.00 | 108,333.0000 | 39,042,445 | 50.00% | 0.28% |
| June 30, 2025 | San Martin Javier | CHIEF MEDICAL OFFICER | M | Common Stock | 46666 | $0.00 | 82,507.0000 | 39,042,445 | 130.20% | 0.12% |
| May 19, 2025 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | A | Common Stock | 10000 | $0.23 | 140,761.0000 | 39,042,445 | 7.65% | 0.03% |
| May 30, 2025 | PICKERING GRANT | Not found | A | Stock Option (Right to Buy) | 20900 | $0.00 | 20,900.0000 | 39,042,445 | 9999.99% | 0.05% |
| May 30, 2025 | FLUKE JOHN M JR | Not found | A | Stock Option (Right to Buy) | 20900 | $0.00 | 20,900.0000 | 39,042,445 | 9999.99% | 0.05% |
| May 30, 2025 | Panzara Michael A. | Not found | A | Stock Option (Right to Buy) | 20900 | $0.00 | 20,900.0000 | 39,042,445 | 9999.99% | 0.05% |
| May 30, 2025 | Romano Kelly A | Not found | A | Stock Option (Right to Buy) | 20900 | $0.00 | 20,900.0000 | 39,042,445 | 9999.99% | 0.05% |
| May 30, 2025 | EDELMAN JOSEPH | Not found | A | Stock Option (Right to Buy) | 20900 | $0.00 | 20,900.0000 | 39,042,445 | 9999.99% | 0.05% |
| May 30, 2025 | JOHNSON JAMES A | Not found | A | Stock Option (Right to Buy) | 20900 | $0.00 | 20,900.0000 | 39,042,445 | 9999.99% | 0.05% |
| May 30, 2025 | Kosacz Barbara | Not found | A | Stock Option (Right to Buy) | 20900 | $0.00 | 20,900.0000 | 39,042,445 | 9999.99% | 0.05% |
| March 3, 2025 | Renninger Robert | SVP, Finance and Accounting | A | Stock Option (Right to Buy) | 73350 | $0.00 | 73,350.0000 | 39,042,445 | 9999.99% | 0.19% |
| March 3, 2025 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 87845 | $0.00 | 87,845.0000 | 39,042,445 | 9999.99% | 0.23% |
| March 3, 2025 | Renninger Robert | SVP, Finance and Accounting | A | Stock Option (Right to Buy) | 58500 | $0.00 | 58,500.0000 | 39,042,445 | 9999.99% | 0.15% |
| March 3, 2025 | Renninger Robert | SVP, Finance and Accounting | A | Stock Option (Right to Buy) | 73350 | $0.00 | 73,350.0000 | 39,042,445 | 9999.99% | 0.19% |
| March 3, 2025 | Renninger Robert | SVP, Finance and Accounting | A | Restricted Stock Units | 39000 | $0.00 | 39,000.0000 | 39,042,445 | 9999.99% | 0.10% |
| March 3, 2025 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | A | Restricted Stock Units | 58563 | $0.00 | 58,563.0000 | 39,042,445 | 9999.99% | 0.15% |
| March 3, 2025 | Litton Mark James | President and CEO | A | Stock Option (Right to Buy) | 333815 | $0.00 | 333,815.0000 | 39,042,445 | 9999.99% | 0.86% |
| March 3, 2025 | Litton Mark James | President and CEO | A | Restricted Stock Units | 222543 | $0.00 | 222,543.0000 | 39,042,445 | 9999.99% | 0.57% |
| March 3, 2025 | San Martin Javier | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 111270 | $0.00 | 111,270.0000 | 39,042,445 | 9999.99% | 0.29% |
| March 3, 2025 | San Martin Javier | CHIEF MEDICAL OFFICER | A | Restricted Stock Units | 74180 | $0.00 | 74,180.0000 | 39,042,445 | 9999.99% | 0.19% |
| March 3, 2025 | Worthington Mark | General Counsel and CCO | A | Restricted Stock Units | 57263 | $0.00 | 57,263.0000 | 39,042,445 | 9999.99% | 0.15% |
| March 3, 2025 | Worthington Mark | General Counsel and CCO | A | Stock Option (Right to Buy) | 85895 | $0.00 | 85,895.0000 | 39,042,445 | 9999.99% | 0.22% |
| Jan. 2, 2025 | San Martin Javier | CHIEF MEDICAL OFFICER | S | Common Stock | 10826 | $0.56 | 35,841.0000 | 0 | 23.20% | 0.00% |
| Dec. 31, 2024 | Worthington Mark | General Counsel and CCO | M | Restricted Stock Units | 36667 | $0.00 | 73,333.0000 | 0 | 33.33% | 0.00% |
| Jan. 2, 2025 | Worthington Mark | General Counsel and CCO | S | Common Stock | 8510 | $0.56 | 83,735.0000 | 0 | 9.23% | 0.00% |
| Dec. 31, 2024 | Worthington Mark | General Counsel and CCO | M | Common Stock | 36667 | $0.00 | 92,245.0000 | 0 | 65.97% | 0.00% |
| Nov. 18, 2024 | Worthington Mark | General Counsel and CCO | A | Common Stock | 3651 | $0.55 | 55,578.0000 | 0 | 7.03% | 0.00% |
| Dec. 31, 2024 | Renninger Robert | VP of Finance | M | Restricted Stock Units | 12359 | $0.00 | 24,718.0000 | 0 | 33.33% | 0.00% |
| Jan. 2, 2025 | Renninger Robert | VP of Finance | S | Common Stock | 2881 | $0.56 | 89,724.0000 | 0 | 3.11% | 0.00% |
| Dec. 31, 2024 | Renninger Robert | VP of Finance | M | Common Stock | 12359 | $0.00 | 92,605.0000 | 0 | 15.40% | 0.00% |
| Nov. 18, 2024 | Renninger Robert | VP of Finance | A | Common Stock | 3651 | $0.55 | 80,246.0000 | 0 | 4.77% | 0.00% |
| Dec. 31, 2024 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | M | Restricted Stock Units | 36667 | $0.00 | 73,333.0000 | 0 | 33.33% | 0.00% |
| Jan. 2, 2025 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 8510 | $0.56 | 130,761.0000 | 0 | 6.11% | 0.00% |
| Dec. 31, 2024 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 36667 | $0.00 | 139,271.0000 | 0 | 35.74% | 0.00% |
| Nov. 18, 2024 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | A | Common Stock | 9920 | $0.55 | 102,604.0000 | 0 | 10.70% | 0.00% |
| Dec. 31, 2024 | Litton Mark James | President and CEO | M | Restricted Stock Units | 108333 | $0.00 | 216,667.0000 | 0 | 33.33% | 0.00% |
| Jan. 2, 2025 | Litton Mark James | President and CEO | S | Common Stock | 25107 | $0.56 | 262,280.0000 | 0 | 8.74% | 0.00% |
| Dec. 31, 2024 | Litton Mark James | President and CEO | M | Common Stock | 108333 | $0.00 | 287,387.0000 | 0 | 60.50% | 0.00% |
| Dec. 31, 2024 | San Martin Javier | CHIEF MEDICAL OFFICER | M | Restricted Stock Units | 46667 | $0.00 | 93,333.0000 | 0 | 33.33% | 0.00% |
| Dec. 31, 2024 | San Martin Javier | CHIEF MEDICAL OFFICER | M | Common Stock | 46667 | $0.00 | 46,667.0000 | 0 | 9999.99% | 0.00% |
| Oct. 1, 2024 | Worthington Mark | General Counsel and CCO | A | Restricted Stock Units | 110000 | $0.00 | 110,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 1, 2024 | Worthington Mark | General Counsel and CCO | A | Stock Option (Right to Buy) | 110000 | $0.00 | 110,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 3, 2024 | Litton Mark James | President and CEO | A | Stock Option (Right to Buy) | 325000 | $0.00 | 325,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 1, 2024 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | A | Restricted Stock Units | 110000 | $0.00 | 110,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 1, 2024 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 110000 | $0.00 | 110,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 1, 2024 | Renninger Robert | VP of Finance | A | Restricted Stock Units | 37077 | $0.00 | 37,077.0000 | 0 | 9999.99% | 0.00% |
| Oct. 1, 2024 | Renninger Robert | VP of Finance | A | Stock Option (Right to Buy) | 37077 | $0.00 | 37,077.0000 | 0 | 9999.99% | 0.00% |
| Oct. 1, 2024 | San Martin Javier | CHIEF MEDICAL OFFICER | A | Restricted Stock Units | 140000 | $0.00 | 140,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 1, 2024 | San Martin Javier | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 140000 | $0.00 | 140,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 3, 2024 | Litton Mark James | President and CEO | A | Restricted Stock Units | 325000 | $0.00 | 325,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 3, 2024 | Litton Mark James | President and CEO | A | Stock Option (Right to Buy) | 325000 | $0.00 | 325,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 5, 2024 | Gengos Andrew | CFO and Chief Business Officer | S | Common Stock | 1272 | $0.57 | 97,532.0000 | 0 | 1.29% | 0.00% |
| Sept. 5, 2024 | Lenington Rachel | COO and CDO | S | Common Stock | 2525 | $0.57 | 20,870.0000 | 0 | 10.79% | 0.00% |
| Sept. 3, 2024 | Lenington Rachel | COO and CDO | A | Common Stock | 10000 | $0.00 | 23,395.0000 | 0 | 74.65% | 0.00% |
| Sept. 5, 2024 | Worthington Mark | GENERAL COUNSEL | S | Common Stock | 2525 | $0.57 | 51,927.0000 | 0 | 4.64% | 0.00% |
| Sept. 3, 2024 | Worthington Mark | GENERAL COUNSEL | A | Common Stock | 10000 | $0.00 | 54,452.0000 | 0 | 22.50% | 0.00% |
| May 20, 2024 | Worthington Mark | GENERAL COUNSEL | A | Common Stock | 10000 | $1.34 | 44,452.0000 | 0 | 29.03% | 0.00% |
| Sept. 5, 2024 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 2525 | $0.57 | 92,684.0000 | 0 | 2.65% | 0.00% |
| Sept. 3, 2024 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | A | Common Stock | 10000 | $0.00 | 95,209.0000 | 0 | 11.74% | 0.00% |
| Sept. 3, 2024 | Litton Mark James | President and CEO | A | Common Stock | 20000 | $0.00 | 184,086.0000 | 0 | 12.19% | 0.00% |
| May 20, 2024 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | A | Common Stock | 4953 | $1.34 | 85,209.0000 | 0 | 6.17% | 0.00% |
| May 20, 2024 | Gengos Andrew | CFO and Chief Business Officer | A | Common Stock | 10000 | $1.34 | 93,804.0000 | 0 | 11.93% | 0.00% |
| Sept. 3, 2024 | Gengos Andrew | CFO and Chief Business Officer | A | Common Stock | 5000 | $0.00 | 98,804.0000 | 0 | 5.33% | 0.00% |
| Sept. 5, 2024 | Litton Mark James | President and CEO | S | Common Stock | 5032 | $0.57 | 179,054.0000 | 0 | 2.73% | 0.00% |
| June 24, 2024 | Romano Kelly A | Not found | P | Common Stock | 27400 | $2.42 | 80,715.0000 | 0 | 51.39% | 0.00% |
| June 21, 2024 | Romano Kelly A | Not found | P | Common Stock | 15000 | $2.26 | 53,315.0000 | 0 | 39.15% | 0.00% |
| May 24, 2024 | Romano Kelly A | Not found | A | Stock Option (Right to Buy) | 20900 | $0.00 | 20,900.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2024 | EDELMAN JOSEPH | Not found | A | Stock Option (Right to Buy) | 20900 | $0.00 | 20,900.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2024 | Kosacz Barbara | Not found | A | Stock Option (Right to Buy) | 20900 | $0.00 | 20,900.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2024 | JOHNSON JAMES A | Not found | A | Stock Option (Right to Buy) | 20900 | $0.00 | 20,900.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2024 | Panzara Michael A. | Not found | A | Stock Option (Right to Buy) | 20900 | $0.00 | 20,900.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2024 | PICKERING GRANT | Not found | A | Stock Option (Right to Buy) | 20900 | $0.00 | 20,900.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2024 | FLUKE JOHN M JR | Not found | A | Stock Option (Right to Buy) | 20900 | $0.00 | 20,900.0000 | 0 | 9999.99% | 0.00% |
| April 15, 2024 | San Martin Javier | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 400000 | $0.00 | 400,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 4, 2024 | Worthington Mark | GENERAL COUNSEL | A | Common Stock | 10000 | $0.00 | 36,864.0000 | 0 | 37.22% | 0.00% |
| Feb. 15, 2024 | Litton Mark James | CEO | A | Stock Option (Right to Buy) | 650000 | $0.00 | 650,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | Worthington Mark | GENERAL COUNSEL | A | Stock Option (Right to Buy) | 220000 | $0.00 | 220,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 220000 | $0.00 | 220,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | Gengos Andrew | CFO AND CHIEF BUSINESS OFFICER | A | Stock Option (Right to Buy) | 280000 | $0.00 | 280,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | Lenington Rachel | COO AND CDO | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2024 | Litton Mark James | CEO | S | Common Stock | 4820 | $2.91 | 164,086.0000 | 0 | 2.85% | 0.00% |
| May 18, 2023 | Worthington Mark | GENERAL COUNSEL | A | Common Stock | 7767 | $2.41 | 26,864.0000 | 0 | 40.67% | 0.00% |
| Jan. 4, 2024 | Lenington Rachel | COO AND CDO | A | Common Stock | 10000 | $0.00 | 15,807.0000 | 0 | 172.21% | 0.00% |
| Jan. 5, 2024 | Lenington Rachel | COO AND CDO | S | Common Stock | 2412 | $2.91 | 13,395.0000 | 0 | 15.26% | 0.00% |
| Jan. 4, 2024 | Litton Mark James | CEO | A | Common Stock | 20000 | $0.00 | 168,906.0000 | 0 | 13.43% | 0.00% |
| Jan. 5, 2024 | Worthington Mark | GENERAL COUNSEL | S | Common Stock | 2412 | $2.91 | 34,452.0000 | 0 | 6.54% | 0.00% |
| Jan. 4, 2024 | Gengos Andrew | CFO AND CHIEF BUSINESS OFFICER | A | Common Stock | 5000 | $0.00 | 85,012.0000 | 0 | 6.25% | 0.00% |
| Jan. 5, 2024 | Gengos Andrew | CFO AND CHIEF BUSINESS OFFICER | S | Common Stock | 1208 | $2.91 | 83,804.0000 | 0 | 1.42% | 0.00% |
| May 18, 2023 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | A | Common Stock | 809 | $2.41 | 69,271.0000 | 0 | 1.18% | 0.00% |
| Nov. 20, 2023 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | A | Common Stock | 3397 | $1.34 | 72,668.0000 | 0 | 4.90% | 0.00% |
| Jan. 4, 2024 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | A | Common Stock | 10000 | $0.00 | 82,668.0000 | 0 | 13.76% | 0.00% |
| Jan. 5, 2024 | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 2412 | $2.91 | 80,256.0000 | 0 | 2.92% | 0.00% |
| Jan. 5, 2023 | CHURCH KEVIN | Chief Scientific Officer | S | Common Stock | 2412 | $2.91 | 80,256.0000 | 0 | 2.92% | 0.00% |
| Jan. 4, 2024 | Lenington Rachel | Chief Operating Officer | A | Common Stock | 10000 | $0.00 | 15,807.0000 | 0 | 172.21% | 0.00% |
| Jan. 5, 2024 | Lenington Rachel | Chief Operating Officer | S | Common Stock | 2412 | $2.91 | 13,395.0000 | 0 | 15.26% | 0.00% |
| Jan. 4, 2024 | MOEBIUS HANS | Chief Medical Officer | A | Common Stock | 10000 | $0.00 | 91,482.0000 | 0 | 12.27% | 0.00% |
| Jan. 4, 2024 | Litton Mark James | Chief Executive Officer | A | Common Stock | 20000 | $0.00 | 168,906.0000 | 0 | 13.43% | 0.00% |
| Jan. 4, 2023 | Gengos Andrew | See Below | A | Common Stock | 5000 | $0.00 | 85,012.0000 | 0 | 6.25% | 0.00% |
| Jan. 5, 2023 | Gengos Andrew | See Below | S | Common Stock | 1208 | $2.91 | 83,804.0000 | 0 | 1.42% | 0.00% |
| Jan. 5, 2024 | Litton Mark James | Chief Executive Officer | S | Common Stock | 4820 | $2.91 | 164,086.0000 | 0 | 2.85% | 0.00% |
| May 18, 2023 | Worthington Mark | General Counsel | A | Common Stock | 7767 | $2.41 | 26,864.0000 | 0 | 40.67% | 0.00% |
| Jan. 4, 2024 | Worthington Mark | General Counsel | A | Common Stock | 10000 | $0.00 | 36,864.0000 | 0 | 37.22% | 0.00% |
| Jan. 5, 2024 | Worthington Mark | General Counsel | S | Common Stock | 2412 | $2.91 | 34,452.0000 | 0 | 6.54% | 0.00% |
| May 18, 2023 | CHURCH KEVIN | Chief Scientific Officer | A | Common Stock | 809 | $2.41 | 69,271.0000 | 0 | 1.18% | 0.00% |
| Nov. 20, 2023 | CHURCH KEVIN | Chief Scientific Officer | A | Common Stock | 3397 | $1.34 | 72,668.0000 | 0 | 4.90% | 0.00% |
| Jan. 4, 2023 | CHURCH KEVIN | Chief Scientific Officer | A | Common Stock | 10000 | $0.00 | 82,668.0000 | 0 | 13.76% | 0.00% |
| Dec. 29, 2023 | PERCEPTIVE ADVISORS LLC | Director | P | Common Stock | 163954 | $2.38 | 5,402,964.0000 | 0 | 3.13% | 0.00% |
| Dec. 28, 2023 | PERCEPTIVE ADVISORS LLC | Director | P | Common Stock | 409598 | $2.44 | 5,239,010.0000 | 0 | 8.48% | 0.00% |
| Dec. 27, 2023 | PERCEPTIVE ADVISORS LLC | Director | P | Common Stock | 32134 | $2.28 | 4,829,412.0000 | 0 | 0.67% | 0.00% |
| June 7, 2023 | Gengos Andrew | See Below | P | Common Stock | 11719 | $3.44 | 80,012.0000 | 0 | 17.16% | 0.00% |
| June 7, 2023 | Gengos Andrew | See Below | P | Common Stock | 2859 | $3.40 | 68,293.0000 | 0 | 4.37% | 0.00% |
| June 7, 2023 | Gengos Andrew | See Below | P | Common Stock | 422 | $3.36 | 65,434.0000 | 0 | 0.65% | 0.00% |
| June 2, 2023 | Gengos Andrew | See Below | P | Common Stock | 10012 | $2.75 | 10,012.0000 | 0 | 9999.99% | 0.00% |
| June 2, 2023 | MOEBIUS HANS | Chief Medical Officer | M | Stock Option (Right to Buy) | 7882 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 2, 2023 | MOEBIUS HANS | Chief Medical Officer | M | Common Stock | 7882 | $1.35 | 81,482.0000 | 0 | 10.71% | 0.00% |
| June 5, 2023 | Gengos Andrew | See Below | P | Common Stock | 10000 | $3.02 | 65,012.0000 | 0 | 18.18% | 0.00% |
| May 18, 2023 | MOEBIUS HANS | Chief Medical Officer | A | Common Stock | 7764 | $2.41 | 73,600.0000 | 0 | 11.79% | 0.00% |
| June 5, 2023 | Gengos Andrew | See Below | P | Common Stock | 10000 | $3.00 | 55,012.0000 | 0 | 22.22% | 0.00% |
| June 5, 2023 | Gengos Andrew | See Below | P | Common Stock | 10000 | $3.00 | 45,012.0000 | 0 | 28.56% | 0.00% |
| June 5, 2023 | Gengos Andrew | See Below | P | Common Stock | 15000 | $3.00 | 35,012.0000 | 0 | 74.96% | 0.00% |
| June 2, 2023 | Gengos Andrew | See Below | P | Common Stock | 3418 | $2.95 | 20,012.0000 | 0 | 20.60% | 0.00% |
| June 2, 2023 | Gengos Andrew | See Below | P | Common Stock | 6582 | $2.86 | 16,594.0000 | 0 | 65.74% | 0.00% |
| May 19, 2023 | Panzara Michael A. | Director | A | Stock Option (Right to Buy) | 20900 | $0.00 | 20,900.0000 | 0 | 9999.99% | 0.00% |
| May 18, 2023 | Gengos Andrew | See Below | A | Stock Options (right to buy) | 400000 | $0.00 | 400,000.0000 | 0 | 9999.99% | 0.00% |
| May 19, 2023 | PICKERING GRANT | Director | A | Stock Option (Right to Buy) | 20900 | $0.00 | 20,900.0000 | 0 | 9999.99% | 0.00% |
| May 19, 2023 | FLUKE JOHN M JR | Director | A | Stock Option (Right to Buy) | 20900 | $0.00 | 20,900.0000 | 0 | 9999.99% | 0.00% |
| May 19, 2023 | EDELMAN JOSEPH | Director | A | Stock Option (Right to Buy) | 20900 | $0.00 | 20,900.0000 | 0 | 9999.99% | 0.00% |
| May 19, 2023 | Kosacz Barbara | Director | A | Stock Option (Right to Buy) | 20900 | $0.00 | 20,900.0000 | 0 | 9999.99% | 0.00% |
| May 19, 2023 | JOHNSON JAMES A | Director | A | Stock Option (Right to Buy) | 20900 | $0.00 | 20,900.0000 | 0 | 9999.99% | 0.00% |
| May 19, 2023 | Romano Kelly A | Director | A | Stock Option (Right to Buy) | 20900 | $0.00 | 20,900.0000 | 0 | 9999.99% | 0.00% |
| March 29, 2023 | PICKERING GRANT | Director | P | Common Stock | 10000 | $2.33 | 10,783.0000 | 0 | 1277.14% | 0.00% |
| March 30, 2023 | PICKERING GRANT | Director | P | Common Stock | 15000 | $2.47 | 25,783.0000 | 0 | 139.11% | 0.00% |
| March 29, 2023 | JOHNSON JAMES A | Director | P | Common Stock | 5000 | $2.40 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| March 24, 2023 | CHURCH KEVIN | Chief Scientific Officer | M | Common Stock | 6410 | $1.35 | 68,462.0000 | 0 | 10.33% | 0.00% |
| March 24, 2023 | CHURCH KEVIN | Chief Scientific Officer | M | Stock Option (Right to Buy) | 6410 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 27, 2023 | Litton Mark James | Chief Executive Officer | A | Stock Option (Right to Buy) | 425000 | $0.00 | 425,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 18, 2022 | Litton Mark James | Chief Executive Officer | A | Common Stock | 662 | $2.74 | 148,906.0000 | 0 | 0.45% | 0.00% |
| Jan. 19, 2023 | MOEBIUS HANS | Chief Medical Officer | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 19, 2023 | Worthington Mark | General Counsel | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 19, 2023 | CHURCH KEVIN | Executive VP, Research | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 19, 2023 | Lenington Rachel | Chief Operating Officer | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 18, 2022 | CHURCH KEVIN | Executive VP, Research | A | Common Stock | 657 | $2.74 | 62,052.0000 | 0 | 1.07% | 0.00% |
| Jan. 19, 2023 | MILESON GLENNA | Chief Financial Officer | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |